Costarelli S - Search Results

1

Influence of hepatitis C genotypes on lipid levels in HIV-positive patients during highly active antiretroviral therapy.

Lapadula G, Torti C, Paraninfo G, Castelnuovo F, Uccelli MC, Costarelli S, Ladisa N, Maserati R, Di Pietro M, De Silvestri A, Tinelli C, Puoti M, Carosi G; EPOKa-A Study Group of the MASTER Cohort. Lapadula G, et al. Among authors: costarelli s. Antivir Ther. 2006;11(4):521-7. Antivir Ther. 2006. PMID: 16856626 Clinical Trial.

2

Influence of folate serum concentration on plasma homocysteine levels in HIV-positive patients exposed to protease inhibitors undergoing HAART.

Uccelli MC, Torti C, Lapadula G, Labate L, Cologni G, Tirelli V, Moretti F, Costarelli S, Quiros-Roldan E, Carosi G. Uccelli MC, et al. Among authors: costarelli s. Ann Nutr Metab. 2006;50(3):247-52. doi: 10.1159/000091682. Epub 2006 Feb 23. Ann Nutr Metab. 2006. PMID: 16508252

3

Influence of viral chronic hepatitis co-infection on plasma drug concentrations and liver transaminase elevations upon therapy switch in HIV-positive patients.

Torti C, Lapadula G, Uccelli MC, Quiros-Roldan E, Regazzi M, Ladisa N, Micheli V, Orani A, Patroni A, Caputo SL, Tirelli V, Di Giambenedetto S, Cologni G, Costarelli S, Gargiulo F, Manca N, Carosi G; RADAR Study Group of MASTER Cohort. Torti C, et al. Among authors: costarelli s. Int J Antimicrob Agents. 2007 Feb;29(2):185-90. doi: 10.1016/j.ijantimicag.2006.08.015. Epub 2006 Oct 2. Int J Antimicrob Agents. 2007. PMID: 17011754

4

Predictors of clinical progression among HIV-1-positive patients starting HAART with CD4+ T-cell counts > or =200 cells/mm3.

Lapadula G, Torti C, Maggiolo F, Casari S, Suter F, Minoli L, Pezzoli C, Di Pietro M, Migliorino G, Ouiros-Roldan E, Ladisa N, Sighinolfi L, Costarelli S, Carosi G; Italian MASTER Cohort. Lapadula G, et al. Among authors: costarelli s. Antivir Ther. 2007;12(6):941-7. Antivir Ther. 2007. PMID: 17926648

5

Evidence of long-term suppression of hepatitis B virus DNA by tenofovir as rescue treatment in patients coinfected by HIV.

Quiros-Roldan E, Calabresi A, Lapadula G, Tirelli V, Costarelli S, Cologni G, Zaltron S, Puoti M, Carosi G, Torti C. Quiros-Roldan E, et al. Among authors: costarelli s. Antivir Ther. 2008;13(3):341-8. Antivir Ther. 2008. PMID: 18572746 Clinical Trial.

6

Prevalence and risk factors for etravirine resistance among patients failing on non-nucleoside reverse transcriptase inhibitors.

Lapadula G, Calabresi A, Castelnuovo F, Costarelli S, Quiros-Roldan E, Paraninfo G, Ceresoli F, Gargiulo F, Manca N, Carosi G, Torti C. Lapadula G, et al. Among authors: costarelli s. Antivir Ther. 2008;13(4):601-5. Antivir Ther. 2008. PMID: 18672539

7

Analysis of severe hepatic events associated with nevirapine-containing regimens: CD4+ T-cell count and gender in hepatitis C seropositive and seronegative patients.

Torti C, Costarelli S, De Silvestri A, Quiros-Roldan E, Lapadula G, Cologni G, Paraninfo G, Castelnuovo F, Puoti M, Carosi G; BHCC Study Group. Torti C, et al. Among authors: costarelli s. Drug Saf. 2007;30(12):1161-9. doi: 10.2165/00002018-200730120-00008. Drug Saf. 2007. PMID: 18035868

8

Plasma HIV load and proviral DNA decreases after two standard antiretroviral regimens in HIV-positive patients naïve to antiretrovirals.

Torti C, Quiros-Roldan ME, Cologni G, Nichelatti M, Ceresoli F, Pinti M, Nasi M, Cossarizza A, Lapadula G, Costarelli S, Manca N, Gargiulo F, Magoni M, Carosi G. Torti C, et al. Among authors: costarelli s. Curr HIV Res. 2008 Jan;6(1):43-8. doi: 10.2174/157016208783571982. Curr HIV Res. 2008. PMID: 18288974 Clinical Trial.

9

Screening and Management of HIV-2-Infected Individuals in Northern Italy.

Costarelli S, Torti C, Rodella A, Baldanti F, Paolucci S, Lapadula G, Manca N, Quiros-Roldan E, Izzo I, Carosi G. Costarelli S, et al. AIDS Patient Care STDS. 2008 Jun;22(6):489-94. doi: 10.1089/apc.2007.0149. AIDS Patient Care STDS. 2008. PMID: 18582190

10

Virological effectiveness and CD4+ T-cell increase over early and late courses in HIV infected patients on antiretroviral therapy: focus on HCV and anchor class received.

Motta D, Brianese N, Focà E, Nasta P, Maggiolo F, Fabbiani M, Cologni G, Di Giambenedetto S, Di Pietro M, Ladisa N, Sighinolfi L, Costarelli S, Castelnuovo F, Torti C. Motta D, et al. Among authors: costarelli s. AIDS Res Ther. 2012 Jun 15;9(1):18. doi: 10.1186/1742-6405-9-18. AIDS Res Ther. 2012. PMID: 22703595 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

46 results

Search Page

Filters